When building your watch list, focus on stocks with an 80 or higher RS Rating. Organon stock is one stock that just reached the mark, now earning a score of 83.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
IBD's proprietary RS Rating measures technical performance by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our database.
Decades of market research shows that the best stocks typically have an RS Rating north of 80 in the early stages of their moves.
Looking For The Best Stocks To Buy And Watch? Start Here
Is Organon Stock A Buy?
Organon stock has been rallying off the bottom, retaking its 200-day moving average. While generic drug maker stock is not near a proper buy point right now, see if it goes on to form and break out from a proper base.
While revenue growth fell last quarter from -1% to -4%, the bottom line grew -16%, up from -28% in the prior report. Keep an eye out for the company's next round of numbers on or around Feb. 16.
Organon stock earns the No. 7 rank among its peers in the Medical-Generic Drugs industry group. Teva Pharmaceutical ADR and ANI Pharmaceuticals are also among the group's highest-rated stocks.
